A detailed history of Kb Financial Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Kb Financial Partners, LLC holds 963 shares of DXCM stock, worth $70,135. This represents 0.03% of its overall portfolio holdings.

Number of Shares
963
Previous 838 14.92%
Holding current value
$70,135
Previous $108,000 16.67%
% of portfolio
0.03%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 15, 2023

BUY
$86.06 - $137.93 $10,757 - $17,241
125 Added 14.92%
963 $90,000
Q2 2023

Aug 14, 2023

BUY
$112.47 - $130.98 $5,960 - $6,941
53 Added 6.75%
838 $108,000
Q4 2022

Feb 17, 2023

SELL
$84.98 - $122.67 $3,654 - $5,274
-43 Reduced 5.19%
785 $89,000
Q3 2022

Nov 14, 2022

SELL
$76.35 - $94.18 $1,221 - $1,506
-16 Reduced 1.9%
828 $67,000
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $47,864 - $93,554
704 Added 502.86%
844 $63,000
Q1 2022

May 17, 2022

BUY
$94.08 - $130.2 $13,171 - $18,228
140 New
140 $72,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $28.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Kb Financial Partners, LLC Portfolio

Follow Kb Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kb Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kb Financial Partners, LLC with notifications on news.